BioMed Central home | Journals A-Z | Feedback | My details

 

This article is part of a series on Indolizidines and quinolizidines: natural products and beyond, edited by Prof Joseph P Michael, University of Witwatersrand.

Open AccessHighly AccessFull Research Paper

Total synthesis of the indolizidine alkaloid tashiromine

Stephen P Marsden and Alison D McElhinney

School of Chemistry, University of Leeds, Leeds LS2 9JT, UK

Beilstein Journal of Organic Chemistry 2008, 4:8doi:10.1186/1860-5397-4-8

The electronic version of this article is the complete one and can be found online at: http://bjoc.beilstein-journals.org/content/4/1/8

Received: 18 October 2007
Accepted: 26 January 2008
Published: 26 January 2008

© 2008 Marsden and McElhinney; licensee Beistein-Institut
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

< previousfull textnext >

Abstract

Background

Tashiromine 1 is a naturally occurring indolizidine alkaloid. It has been the subject of thirteen successful total syntheses to date. Our own approach centres on the stereoselective construction of the indolizidine core by capture of an electrophilic acyliminium species by a pendant allylsilane. The key cyclisation precursor is constructed using olefin cross-metathesis chemistry, which has the potential to facilitate both racemic and asymmetric approaches, depending upon the choice of the allylsilane metathesis partner.

Results

The use of the allyltrimethylsilane cross-metathesis approach enables the rapid construction of the key cyclisation precursor 3 (3 steps from commercial materials), which undergoes acid-induced cyclisation to give the desired bicyclic indolizidine skeleton as a 96:4 mixture of diastereomers. Simple functional group interconversions allowed the completion of the total synthesis of racemic tashiromine in six steps (19% overall yield). Three chiral α-alkoxyallylsilanes (12,14 and 15) were prepared in enantioenriched form and their cross-metathesis reactions studied as part of a putative asymmetric approach to tashiromine. In the event, α-hydroxysilane 12 underwent isomerisation under the reaction conditions to acylsilane 17, while silanes 14 and 15 were unreactive towards metathesis.

Conclusion

A concise, stereoselective total synthesis of racemic tashiromine has been developed. Attempts to translate this into an asymmetric synthesis have thus far been unsuccessful.

Background

Tashiromine (1) is a naturally occurring indolizidine, isolated from an Asian deciduous shrub Maackia tashiroi. [1] As one of the structurally simpler indolizidine alkaloids, [2] tashiromine has been a popular target for synthetic chemists, and to date has succumbed to total synthesis on thirteen occasions. [3-15] A wide variety of reactions have been employed to assemble the core indolizidine structure, including radical cyclisations;[3] nucleophilic addition to imines;[5,14,15] electrophilic alkylation of pyrroles;[7,13] alkylation of enamines,[6] β-amino esters [8] and pyrrolidinyllithiums;[12] stereoselective reduction of enamines [4,9] and pyridinium salts; [11] and titanium-mediated reductive imide-olefin cyclisation. [10] Our own approach [14] utilises an intramolecular addition of an allylsilane to an N-acyliminium ion to deliver the [4.3.0]-azabicyclic (indolizidine) skeleton 2 (Scheme 1), wherein the pendant vinyl group acts as a handle to install the hydroxymethyl sidechain found in tashiromine. The synthesis of azabicyclic assemblies by intramolecular allylsilane/N-acyliminium cyclisations was first studied by Hiemstra and Speckamp,[16] who prepared their functionalised allylsilane cyclisation precursors (such as 3) by alkylation of cyclic imides with reagent 4 (X = OMs). This, in turn, was prepared in four steps by alkylation of an acetylide anion with commercially available iodomethyltrimethylsilane, followed by partial reduction of the alkyne. Alternative synthetic approaches to 4 (X = OMs, I) involve olefination of aldehydes using the Seyferth-Fleming phosphorane [17] or nickel-catalysed 1,2-metallate rearrangement of lithiated dihydropyran. [18] Our approach was informed by the prior work by our own group [19-24] and others [25-38] on the use of olefin metathesis to generate functionalised allylsilanes. Specifically, cross-metathesis of N-pentenylsuccinimide 5 with allyltrimethylsilane 6 [39] followed by chemoselective partial reduction of the imide would give the cyclisation precursor 3 in short order. Further, the use of chiral allylsilanes as cross-metathesis partners would potentially facilitate an asymmetric approach to the total synthesis of 1. We report herein full details of the successful synthesis of racemic tashiromine 1 by this strategy,[14] as well as our initial attempts towards an asymmetric variant.

Scheme 1

Retrosynthesis for tashiromine

Results and discussion

Metathesis precursor 5 was prepared by alkylation of the sodium salt of succinimide with 5-bromo-1-pentene in near quantitative yield (Scheme 2, see Additional File 1 for full experimental data). The key cross-metathesis reaction of 5 was carried out using a fourfold excess of allyltrimethylsilane 6 and 5 mol% of Grubbs' second generation catalyst in refluxing dichloromethane. The desired product 7 was formed in 73% yield as an inseparable 3:1 mixture of E- and Z-isomers. Partial reduction with sodium borohydride generated the cyclisation precursor 3 in 86% yield, again as a 3:1 mixture of olefin isomers. Exposure of this mixture to trifluoroacetic acid in dichloromethane at room temperature gave the bicyclic amide 2 in 85% yield as a 96:4 mixture of diastereomers. The identity of the major diastereomer was confirmed by comparison of the spectral data with those of Hiemstra:[16] specifically, the signal for the (ring-fusion) proton at C6 for the major diastereomer appeared as a doublet of triplets with δ = 3.19 ppm, whereas the corresponding signal for the minor diastereomer appeared at δ = 3.67 ppm. The stereochemical outcome of this reaction was rationalised on the basis of the model shown in Scheme 2, whereby nucleophilic addition of the allylsilane to the N-acyliminium ion occurs through a chair-like transition state with the nascent alkene equatorially disposed.

Additional file 1. tashirofullsuppinfo. full experimental details and compound characterisation data for all new compounds described.

Format: PDF Size: 105KB Download file

This file can be viewed with: Adobe Acrobat Reader

Scheme 2

Stereoselective construction of the indolizidine core 2

All that remained to complete the synthesis of tashiromine 1 was to effect the oxidative cleavage of the C5 vinyl substituent, then carry out a global reduction of the resulting carbonyl function and the amide. In the event, attempts to form a C5 aldehyde using either ozonolytic or dihydroxylation/periodate alkene cleavage protocols were unsuccessful, with complex mixtures being obtained in both cases. We suspected that the problem lay in the potential for the desired aldehyde to undergo retro-Mannich fragmentation, and so elected to carry out a reductive work-up to the ozonolysis procedure (Scheme 3). The desired alcohol 8 was obtained in a crude form and immediately subjected to reduction with lithium aluminium hydride to give our target tashiromine 1 in 36% yield over two steps. Our stereochemical assignment for the cyclisation of 3 was further corroborated by the agreement of the spectral data for 1 with those previously published in the literature. [3-5,9-12] Additionally, the spectral data for the diastereomeric epi-tashiromine have been reported and differ significantly from those recorded for 1. [10]

Scheme 3

Completion of the total synthesis of tashiromine 1

Having completed our target synthesis, our next goal was to investigate an asymmetric approach to tashiromine. Specifically, we envisaged that cyclisation precursors of type 9 ought to be readily available by cross-metathesis of 5 with an appropriate chiral allylsilane followed by chemoselective partial reduction by borohydride. Thereafter, exposure to acid would generate an N-acyliminium ion, which would cyclise through a chair-like transition state with the nascent alkenyl side-chain equatorially disposed, as in the racemic series (Figure 1). The absolute stereochemistry of the newly established asymmetric centres would be controlled by allylic strain arguments, assuming that the well-established precedent for anti-SE2' attack of the iminium on the allylsilane was upheld here. [40] Thus, the predicted major stereoisomer 10 would have (5S, 6S) stereochemistry and an E-configured side-chain, while cyclisation to the predicted minor (5R, 6R) isomer 11 would be disfavoured by A1,3-interactions between the R1 group and vinylic proton (leading to the Z-configured side-chain). This would represent an immolative transfer of chirality approach to tashiromine, since the olefinic side-chains would be cleaved to install the hydroxymethyl side-chain required by the natural product.

thumbnailFigure 1. Rationale for stereoselective assembly of the indolizidine core using chiral allylsilanes.

Our approach centred on the readily availability of chiral α-hydroxysilane 12 in enantioenriched format. [41] Protection of the hydroxyl group, either before or after cross-metathesis, would allow access to chiral allylsilanes 9 with R1 being an alkoxy or acyloxy group. Furthermore, this would generate products 10 and/or 11 with a readily oxidised enol-ether/ester side chain for progression to tashiromine. We were, of course, mindful that these functions could potentially act as nucleophiles themselves in the acidic medium of the electrophilic cyclisation, and the investigation of such chemoselectivity issues provided a further impetus for this study. Acylsilane 13 was therefore prepared from propargyl alcohol in four steps then subjected to asymmetric reduction with (-)-DIPCl according to Buynak et al (Scheme 4). [41] The desired hydroxysilane 12 was obtained in 53% yield and with 91% ee as determined by chiral HPLC analysis. Compound 12 was converted by standard methods to the acetate 14 and the tetrahydropyranyl ether 15. The latter compound was formed as a 1.3:1 mixture of diastereomers which were partially separated by column chromatography – all subsequent reactions were carried out on diastereomerically pure material for ease of analysis.

Scheme 4

Asymmetric synthesis of chiral (alkoxy)allylsilanes

With the requisite enantioenriched allylsilanes in hand, we next investigated their behaviour in olefin cross-metathesis reactions. Unfortunately, neither 14 nor 15 reacted with 5 under the standard cross-metathesis conditions used for trimethylsilane 6; the use of more forcing conditions (elevated temperature and higher catalyst loadings) did not effect the desired transformation, the only product observed being that of homodimerisation of 5 (Scheme 5).

Scheme 5

Attempted cross-metathesis of (alkoxy)allylsilanes

Finally, we examined the behaviour of alcohol 12 under cross-metathesis conditions. In the event, two isomerised products were isolated from this reaction (Scheme 6): the internal alkene 16 (formed in 99% yield as a ca. 3:1 mixture of E:Z isomers) and the acylsilane 17. The formation of isomerised alkenes accompanying (or instead of) metathesis processes using ruthenium-based catalysts is well documented, [42-63] as is the formation of carbonyl compounds by isomerisation of the corresponding allylic alcohols. [64-68] At this stage we therefore reluctantly abandoned our investigations into the asymmetric synthesis of tashiromine.

Scheme 6

Competing isomerisation processes in attempted cross-metathesis of (hydroxy)allylsilane 12

Conclusion

A concise, stereoselective total synthesis of racemic tashiromine has been developed (six steps from succinimide, 19% overall yield) in which the key steps are the preparation of a functionalised allylsilane by olefin cross-metathesis and the construction of the indolizidine core by intramolecular addition of the allylsilane to an N-acyliminium ion. Attempts to translate this into an asymmetric synthesis utilising cross-metathesis reactions of chiral α-alkoxysilanes have thus far been unsuccessful.

Additional material

Experimental protocols for the synthesis of tashiromine 1 and the preparation of silanes 12, 14, 15 and 17 available as additional file 1.

Acknowledgements

We thank the EPSRC for a studentship (ADM) and Pfizer and Merck for generous unrestricted research funding.

References

  1. Ohmiya S, Kubo H, Otomasu H, Saito K, Murakoshi I:

    Heterocycles. 1990, 30:537-542. OpenURL

  2. Michael JP:

    Natural Product Reports. 2007, 24:191-222. PubMed Abstract | Publisher Full Text OpenURL

    and references therein

  3. Beckwith ALJ, Westwood SW:

    Tetrahedron. 1989, 45:5269-5282. Publisher Full Text OpenURL

  4. Haddad M, Celerier JP, Haviari G, Lhommet G, Dhimane H, Pommelet JC, Chuche J:

    Heterocycles. 1990, 31:1251-1260. OpenURL

  5. Nagao Y, Dai W-M, Ochiai M, Tsukagoshi S, Fujita E:

    J Org Chem. 1990, 55:1148-1156. Publisher Full Text OpenURL

  6. Paulvannan K, Stille JR:

    J Org Chem. 1994, 59:1613-1620. Publisher Full Text OpenURL

  7. Gage JL, Branchaud BP:

    Tetrahedron Lett. 1997, 38:7007-7010. Publisher Full Text OpenURL

  8. Ha D-C, Park S-H, Choi K-S, Yun C-S:

    Bull Korean Chem Soc. 1998, 19:728-730. OpenURL

  9. David O, Blot J, Bellec C, Fargeau-Bellassoued M-C, Haviari G, Celerier J-P, Lhommet G, Gramain J-C, Gardette D:

    J Org Chem. 1999, 64:3122-3131. PubMed Abstract | Publisher Full Text OpenURL

  10. Kim S-H, Kim S-I, Lai S, Cha JK:

    J Org Chem. 1999, 64:6771-6775. PubMed Abstract | Publisher Full Text OpenURL

  11. Bates RW, Boonsombat J:

    J Chem Soc, Perkin Trans 1. 2001, 654-656. Publisher Full Text OpenURL

  12. Dieter RK, Watson R:

    Tetrahedron Lett. 2002, 43:7725-7728. Publisher Full Text OpenURL

  13. Banwell MG, Beck DAS, Smith JA:

    Org Biomol Chem. 2004, 2:157-159. PubMed Abstract | Publisher Full Text OpenURL

  14. McElhinney AD, Marsden SP:

    Synlett. 2005, 2528-2530. Publisher Full Text OpenURL

  15. Belanger G, Larouche-Gauthier R, Menard F, Nantel M, Barabe F:

    J Org Chem. 2006, 71:704-712. PubMed Abstract | Publisher Full Text OpenURL

  16. Hiemstra H, Sno MHAM, Vijn RJ, Speckamp WN:

    J Org Chem. 1985, 50:4014-4020. Publisher Full Text OpenURL

  17. Paquette LA, Mendez-Andino JL:

    J Org Chem. 1998, 63:9061-9068. Publisher Full Text OpenURL

  18. Bergmeier SC, Seth PP:

    J Org Chem. 1997, 62:2671-2674. PubMed Abstract | Publisher Full Text OpenURL

  19. Cassidy JH, Marsden SP:

    Synlett. 1997, 1411-1413. Publisher Full Text OpenURL

  20. Miles SM, Marsden SP, Leatherbarrow RJ, Coates WJ:

    J Org Chem. 2004, 69:6874-6882. PubMed Abstract | Publisher Full Text OpenURL

  21. Miles SM, Marsden SP, Leatherbarrow RJ, Coates WJ:

    Chem Commun. 2004, 2292-2293. Publisher Full Text OpenURL

  22. Akindele T, Marsden SP, Cumming JG:

    Org Lett. 2005, 7:3685-3688. PubMed Abstract | Publisher Full Text OpenURL

  23. Akindele T, Marsden SP, Cumming JG:

    Tetrahedron Lett. 2005, 46:7235-7238. Publisher Full Text OpenURL

  24. Cassidy JH, Farthing CN, Marsden SP, Pedersen A, Slater M, Stemp G:

    Org Biomol Chem. 2006, 4:4118-4126. PubMed Abstract | Publisher Full Text OpenURL

  25. Teare H, Huguet F, Tredwell M, Thibaudeau S, Luthra S, Gouverneur V: [http:/ / content.arkat-usa.org/ ARKIVOC/ JOURNAL_CONTENT/ manuscripts/ 2007/ AK-2285GP as published mainmanuscri pt.pdf] webcite

    ARKIVOC. 2007, 232-244. OpenURL

  26. Thibaudeau S, Gouverneur V:

    Org Lett. 2003, 5:4891-4893. PubMed Abstract | Publisher Full Text OpenURL

  27. Alvarez Corral M, Lopez Sanchez C, Jimenez Gonzalez L, Rosales A, Munoz Dorado M, Rodriguez Garcia I:

    Beilstein J Org Chem. 2007, 3. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  28. Jimenez Gonzalez L, Garcia Munoz S, Alvarez Corral M, Munoz Dorado M, Rodriguez Garcia I:

    Chem Eur J. 2007, 13:557-568. Publisher Full Text OpenURL

  29. Jimenez Gonzalez L, Garcia Munoz S, Alvarez Corral M, Munoz Dorado M, Rodriguez Garcia I:

    Chem Eur J. 2006, 12:8762-8769. Publisher Full Text OpenURL

  30. Garcia Munoz S, Jimenez Gonzalez L, Alvarez Corral M, Munoz Dorado M, Rodriguez Garcia I:

    Synlett. 2005, 3011-3013. Publisher Full Text OpenURL

  31. Jimenez Gonzalez L, Alvarez Corral M, Munoz Dorado M, Rodriguez Garcia I:

    Chem Commun. 2005, 2689-2691. Publisher Full Text OpenURL

  32. Vedrenne E, Dupont H, Oualef S, Elkaim L, Grimaud L:

    Synlett. 2005, 670-672. Publisher Full Text OpenURL

  33. He A, Yan B, Thanavaro A, Spilling CD, Rath NP:

    J Org Chem. 2004, 69:8643-8651. PubMed Abstract | Publisher Full Text OpenURL

  34. BouzBouz S, De Lemos E, Cossy J:

    Adv Synth Cat. 2002, 344:627-630. Publisher Full Text OpenURL

  35. Meyer C, Cossy J:

    Tetrahedron Lett. 1997, 38:7861-7864. Publisher Full Text OpenURL

  36. Taylor RE, Engelhardt FC, Schmitt MJ, Yuan H:

    J Am Chem Soc. 2001, 123:2964-2969. Publisher Full Text OpenURL

  37. Taylor RE, Engelhardt FC, Yuan H:

    Org Lett. 1999, 1:1257-1260. Publisher Full Text OpenURL

  38. Chang SB, Grubbs RH:

    Tetrahedron Lett. 1997, 38:4757-4760. Publisher Full Text OpenURL

  39. Crowe WE, Goldberg DR, Zhang ZJ:

    Tetrahedron Lett. 1996, 37:2117-2120. Publisher Full Text OpenURL

  40. Fleming I, Barbero A, Walter D:

    Chem Rev. 1997, 97:2063-2192. PubMed Abstract | Publisher Full Text OpenURL

  41. Buynak JD, Strickland JB, Lamb GW, Khasnis D, Modi S, Williams D, Zhang H:

    J Org Chem. 1991, 56:7076-7083. Publisher Full Text OpenURL

  42. Miller SJ, Blackwell HE, Grubbs RH:

    J Am Chem Soc. 1996, 115:9606-9614. Publisher Full Text OpenURL

  43. Hoye TR, Promo MA:

    Tetrahedron Lett. 1999, 40:1429-1432. Publisher Full Text OpenURL

  44. Maynnard HD, Grubbs RH:

    Tetrahedron Lett. 1999, 40:4137-4140. Publisher Full Text OpenURL

  45. Edwards SD, Lewis T, Taylor RJK:

    Tetrahedron Lett. 1999, 40:4267-4270. Publisher Full Text OpenURL

  46. Fürstner A, Thiel OR, Ackermann L, Schanz H-J, Nolan SP:

    J Org Chem. 2000, 65:2204-2207. PubMed Abstract | Publisher Full Text OpenURL

  47. Cadot C, Dalko PI, Cossy J:

    Tetrahedron Lett. 2002, 43:1839-1841. Publisher Full Text OpenURL

  48. Arisawa M, Terada Y, Nakagawa M, Nishida A:

    Angew Chem, Int Ed. 2002, 41:4732-4734. Publisher Full Text OpenURL

  49. Sutton AE, Seigal BA, Finnegan DF, Snapper ML:

    J Am Chem Soc. 2002, 124:13390-13391. PubMed Abstract | Publisher Full Text OpenURL

  50. Wipf P, Rector SR, Takahashi H:

    J Am Chem Soc. 2002, 124:14848-14849. PubMed Abstract | Publisher Full Text OpenURL

  51. Schmidt B:

    Eur J Org Chem. 2003, 68:816-819. Publisher Full Text OpenURL

  52. Sworen JC, Pawlow JH, Case W, Lever J, Wagener KB:

    J Mol Cat A. 2003, 194:69-78. Publisher Full Text OpenURL

  53. Lehman SE, Schwendeman JE, O'Donnell PM, Wagener KB:

    Inorg Chim Acta. 2003, 345:190-198. Publisher Full Text OpenURL

  54. Peczuh MW, Snyder NL:

    Tetrahedron Lett. 2003, 44:4057-4061. Publisher Full Text OpenURL

  55. Alcaide B, Almendros P, Alonso JM:

    Chem Eur J. 2003, 9:5793-5799. Publisher Full Text OpenURL

  56. Kotha S, Mandal K:

    Tetrahedron Lett. 2004, 45:1391-1394. Publisher Full Text OpenURL

  57. Schmidt B:

    J Org Chem. 2004, 69:7672-7687. PubMed Abstract | Publisher Full Text OpenURL

  58. Hong SH, Sanders DP, Lee CW, Grubbs RH:

    J Am Chem Soc. 2005, 127:17160-1716. PubMed Abstract | Publisher Full Text OpenURL

  59. Bennasar ML, Roca T, Monerris M, Garcia-Diaz D:

    J Org Chem. 2006, 71:7028-7034. PubMed Abstract | Publisher Full Text OpenURL

  60. Hanessian S, Giroux S, Larsson A:

    Org Lett. 2006, 8:5481-5484. PubMed Abstract | Publisher Full Text OpenURL

  61. Courchay FC, Sworen JC, Ghiviriga I, Abboud KA, Wagener KB:

    Organometallics. 2006, 25:6074-6086. Publisher Full Text OpenURL

  62. Raju R, Allen LJ, Le T, Taylor CD, Howell AR:

    Org Lett. 2007, 9:1699-1701. PubMed Abstract | Publisher Full Text OpenURL

  63. Moiese J, Arseniyadis S, Cossy J:

    Org Lett. 2007, 9:1695-1698. PubMed Abstract | Publisher Full Text OpenURL

  64. Gurjar MK, Yakambram P:

    Tetrahedron Lett. 2001, 42:3633-3636. Publisher Full Text OpenURL

  65. Greenwood ES, Parsons PJ, Young MJ:

    Synth Commun. 2003, 33:223-228. Publisher Full Text OpenURL

  66. Werner H, Grunwald C, Stuer W, Wolf J:

    Organometallics. 2003, 22:1558-1560. Publisher Full Text OpenURL

  67. Edlin CD, Faulkner J, Fengas D, Knight CK, Parker J, Preece I, Quayle P, Richards SN:

    Synlett. 2005, 572-576. Publisher Full Text OpenURL

  68. Finnegan D, Seigal BA, Snapper ML:

    Org Lett. 2006, 8:2603-2606. PubMed Abstract | Publisher Full Text OpenURL

< previousfull textnext >

 
Published by the Beilstein-Institut
in co-operation with BioMed Central
© 1999-2009 Beilstein-Institut unless otherwise stated.